Table 1.
A list of final attributes and levels
| Attribute | Description |
|---|---|
| Duration of symptom control after each dose | 4–6 h |
| 10 h | |
| 12 h | |
| Degree of symptom control after each dose | Minimally improved |
| Much improved | |
| Very much improved | |
| Potential of treatment being abused/misuseda | 1 in 5 (20 %) adolescents |
| 1 in 10 (10 %) adolescents | |
| 0 (0 %) adolescents | |
| Frequency of medication | 3 times/day |
| 2 times/day | |
| Once/day | |
| Side effect of vomiting | 1 in 10 (10 %) children/adolescents |
| 1 in 20 (5 %) children/adolescents | |
| 1 in 100 (1 %) children/adolescents | |
| Side effect of loss of appetite | 1 in 10 (10 %) children/adolescents |
| 1 in 20 (5 %) children/adolescents | |
| 1 in 100 (1 %) children/adolescents | |
| Side effect of sleep disturbance | 1 in 5 (20 %) children/adolescents |
| 1 in 10 (10 %) children/adolescents | |
| 1 in 100 (1 %) children/adolescents |
aThis attribute was presented in the adolescent survey only because it was considered inappropriate to ask the parents of children about the risks of substance misuse